10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
Mayo Clin Proc
; 56(3): 185-95, 1981 Mar.
Article
em En
| MEDLINE
| ID: mdl-7010003
In this three-part series, the first part described the role of platelets in thrombogenesis, this second part considers the pharmacologic effects of platelet-inhibitor drugs, and the third part will discuss their clinical application. This second article comprises (1) the physiologic contribution of the vessel wall to the prevention of thrombosis, particularly the role of prostacyclin, (2) the mechanisms of action of platelet-inhibitor drugs in the prevention of thrombosis, (3) the ideal dose and ideal therapeutic combinations of conventional platelet-inhibitor drugs, (4) other agents and new agents that inhibit platelet function, and (5) drug side effects.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Trombose
/
Prostaglandinas
/
Epoprostenol
/
Fibrinolíticos
Limite:
Humans
Idioma:
En
Revista:
Mayo Clin Proc
Ano de publicação:
1981
Tipo de documento:
Article